Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
ALTME:EPA
TME Pharma NV
€0.079
+1.93%
(+0.0015) 1D
May 8, 5:35:21 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALTME...
Open
€0.08
High
€0.08
Low
€0.08
Mkt. cap
8.72M
Avg. vol.
286.42K
Volume
209.06K
52-wk high
€0.15
52-wk low
€0.05
EPS
-€0.08
No. of employees
12
News stories
From sources across the web
Profile
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller. TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror." The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
About TME Pharma NV
CEOAram Mangasarian
Employees12
Founded1997
Headquarters-
SectorBiotechnology
Websitetmepharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
-
-
13.50K
13.50K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
598.00K
598.00K
504.50K
504.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
669.00K
669.00K
487.50K
487.50K
Operating expense
1.26M
1.26M
982.00K
982.00K
Total operating expenses
1.26M
1.26M
982.00K
982.00K
Operating income
-1.26M
-1.26M
-968.50K
-968.50K
Other non operating income
25.00K
25.00K
-85.00K
-85.00K
EBT including unusual items
-1.24M
-1.24M
-1.05M
-1.05M
EBT excluding unusual items
-1.24M
-1.24M
-1.08M
-1.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-6.50K
-6.50K
-10.00K
-10.00K
Net income
-1.24M
-1.24M
-1.05M
-1.05M
Net profit margin
-
-
-7,785.19%
-7,785.19%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-500.00
-500.00
-23.50K
-23.50K
Net interest expenses
-500.00
-500.00
-23.50K
-23.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.25M
-1.26M
-965.00K
-965.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer